Odyssey Health, Inc. (ODYY) stock
Close on Oct 19, 2026Market cap $746.34KP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jul 31, 2026
Valuation
- Market cap
- $746.34K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$5.73M
- EPS, diluted
- -$0.05
- Book value per share
- -$0.11
- Diluted shares
- 111M
Trading
- Previous close
- $0.01
- Open
- $0.01
- Day's range
- $0.01 – $0.01
- Volume
- 26,030
- Average volume (20 days)
- 78,912
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | ODYY | S&P 500 | Difference | ODYY per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -57.3% | +0.6% | −58.0 pts | ||
| 3 months | +4.7% | +3.4% | +1.3 pts | ||
| Year to date | -79.6% | +13.3% | −92.9 pts | ||
| 1 year | -93.6% | +16.6% | −110.2 pts | ||
| 3 years | -93.3% | +86.4% | −179.7 pts | -59.4% | +23.1% |
| 5 years | -97.9% | +81.9% | −179.8 pts | -53.9% | +12.7% |
Thirteen years at a glance
Fiscal years 2014 to 2026, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Odyssey Health filed with the SEC as exhibits to Form 8-K or 6-K
- Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue GrowthNews
- News
- News
- Update
- News
- Update
About Odyssey Health
Surgical & Medical Instruments & Apparatus
Odyssey Health, Inc. is a medical technology company focused on acquiring and developing medical devices and technologies designed to address unmet clinical needs. The company operates across a single business segment and is developing two primary product candidates: CardioMap, a non-invasive heart monitoring and screening device intended to detect early signs of coronary heart disease, and Save-A-Life, an emergency choking rescue device designed to clear lodged obstructions from a victim's throat using vacuum suction. Odyssey Health does not currently market or sell any products commercially, as its technologies remain in development and require regulatory clearances, such as Food and Drug Administration approvals, prior to commercialization.
Company profile, executives and historyOdyssey Health stock: common questions
What is Odyssey Health's stock price?
ODYY closed at $0.01 on Oct 19, 2026, down 16.25% on the day.
What is Odyssey Health's market cap?
Odyssey Health was worth $746.34K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is ODYY's P/E ratio?
Odyssey Health lost money over the twelve months to Jul 31, 2026 (diluted EPS -$0.05), so it has no meaningful P/E ratio.
Does Odyssey Health pay a dividend?
No. Odyssey Health has not paid a cash dividend over the last twelve months.
How has ODYY stock performed over the past year?
Including dividends, ODYY returned -93.6% over the past year, against +16.6% for the S&P 500.
Who are Odyssey Health's competitors?
Companies most similar to Odyssey Health by business, industry and size include NUMD, DAVI, OBIO, BEAT, EBRCZ.
See a number that looks wrong?